Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warminsko-Mazurski W OlsztyniefiledCriticalUniwersytet Warminsko-Mazurski W Olsztynie
Priority to PL120512UpriorityCriticalpatent/PL120512U1/en
Publication of PL120512U1publicationCriticalpatent/PL120512U1/en
Infusion, Injection, And Reservoir Apparatuses
(AREA)
Abstract
Aparat do iniekcji hormonalnych; przeprowadzanych bezposrednio do gonad, sklada sie z dwóch zespolonych ze soba na stale czesci, nasadki (1) na igle (3) i pierscienia blokujacego (2).Apparatus for hormonal injections; carried out directly to the gonads, consists of two permanently joined together, caps (1) on the needle (3) and the locking ring (2).
PL120512U2011-11-182011-11-18Apparatus for the injection of hormone
PL120512U1
(en)
Method for the treatment of hepatitis c (hcv) comprising administering a compound of formula (i), (ii) or (iii) in combination with one or more therapeutic agents; pharmaceutical composition
Tricyclic derivative compounds with activity on nuclear hormone receptors; pharmaceutical composition that includes them; intermediate compound repair process; and use in the treatment of AIDS, acute adrenal insufficiency, addison's disease, allergic rhinitis, Alzheimer's disease, among others.
Compounds derived from 6.7-dihydro -5h-benzo- (7) anulene, selective estrogen receptor modulators; a medication that they comprise; and its use as a male and female hormone replacement therapy.
Compounds derived from l-glutamic acid and l-glutamine labeled with [f-18]; preparation procedure; pharmaceutical composition comprising the compounds and their use as agents in the diagnosis of tumors.